Induction mortality risk in adult acute myeloid leukemia

被引：1
|
作者：
Tsimberidou, Apostolia-Maria [1 ]
Estey, Elihu [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Unit 428, Houston, TX 77030 USA
来源：
LEUKEMIA & LYMPHOMA | 2006年 / 47卷 / 07期
关键词：
D O I：
10.1080/10428190600709150
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1199 / 1200
页数：2
相关论文
共 50 条
  • [1] ETOPOSIDE IN REMISSION INDUCTION OF ADULT ACUTE MYELOID-LEUKEMIA
    LEONI, F
    CIOLLI, S
    PATRIARCHI, S
    MORFINI, M
    FERRINI, PR
    [J]. ACTA HAEMATOLOGICA, 1990, 83 (02) : 82 - 85
  • [2] Typhlitis complicating induction therapy in adult acute myeloid leukemia
    Pastore, D
    Specchia, G
    Mele, G
    Montagna, MT
    Margari, A
    Carluccio, P
    Nacchiero, M
    Liso, V
    [J]. LEUKEMIA & LYMPHOMA, 2002, 43 (04) : 911 - 914
  • [3] Role of daunorubicin in the induction therapy for adult acute myeloid leukemia
    Usui, N
    Dobashi, N
    Kobayashi, T
    Yano, S
    Maki, N
    Asai, O
    Saito, T
    Yamaguchi, Y
    Watanabe, H
    Kato, A
    Ogihara, A
    Katori, M
    Nagamine, M
    Takei, Y
    Yamazaki, H
    Funakoshi, S
    Tajima, N
    Ogawa, M
    Kuraishi, Y
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) : 2086 - 2092
  • [4] Acute myeloid leukemia induction with cladribine: Outcomes by age and leukemia risk
    Schoen, Martin W.
    Woelich, Susan K.
    Braun, James T.
    Reddy, Dhinesh V.
    Fesler, Mark J.
    Petruska, Paul J.
    Freter, Carl E.
    Lionberger, Jack M.
    [J]. LEUKEMIA RESEARCH, 2018, 68 : 72 - 78
  • [5] Acute Myeloid Leukemia Induction with Cladribine: Effects of Age and Leukemia Risk
    Schoen, Martin W.
    Woelich, Susan K.
    Braun, James T.
    Fesler, Mark J.
    Petruska, Paul J.
    Freter, Carl E.
    Lionberger, Jack M.
    [J]. BLOOD, 2016, 128 (22)
  • [6] AGE FACTOR ON REMISSION INDUCTION THERAPY FOR ADULT ACUTE MYELOID LEUKEMIA
    Kim, H.
    Kim, H. J.
    Min, Y. H.
    Hong, D. S.
    Kim, H. J.
    Park, J.
    Shin, H. J.
    Lee, W. S.
    Park, Y.
    Park, S. K.
    [J]. HAEMATOLOGICA, 2016, 101 : 384 - 384
  • [7] Adult acute myeloid leukemia
    Jabbour, EJ
    Estey, E
    Kantarjian, HM
    [J]. MAYO CLINIC PROCEEDINGS, 2006, 81 (02) : 247 - 260
  • [8] Phase II trial of CPX-351 in patients with acute myeloid leukemia at high risk for induction mortality
    Issa, Ghayas C.
    Kantarjian, Hagop M.
    Xiao, Lianchun
    Ning, Jing
    Alvarado, Yesid
    Borthakur, Gautam
    Daver, Naval
    DiNardo, Courtney D.
    Jabbour, Elias
    Bose, Prithviraj
    Jain, Nitin
    Kadia, Tapan M.
    Naqvi, Kiran
    Pemmaraju, Naveen
    Takahashi, Koichi
    Verstovsek, Srdan
    Andreeff, Micheal
    Kornblau, Steven M.
    Estrov, Zeev
    Ferrajoli, Alessandra
    Garcia-Manero, Guillermo
    Ohanian, Maro
    Wierda, William G.
    Ravandi, Farhad
    Cortes, Jorge E.
    [J]. LEUKEMIA, 2020, 34 (11) : 2914 - 2924
  • [9] Phase II trial of CPX-351 in patients with acute myeloid leukemia at high risk for induction mortality
    Ghayas C. Issa
    Hagop M. Kantarjian
    Lianchun Xiao
    Jing Ning
    Yesid Alvarado
    Gautam Borthakur
    Naval Daver
    Courtney D. DiNardo
    Elias Jabbour
    Prithviraj Bose
    Nitin Jain
    Tapan M. Kadia
    Kiran Naqvi
    Naveen Pemmaraju
    Koichi Takahashi
    Srdan Verstovsek
    Micheal Andreeff
    Steven M. Kornblau
    Zeev Estrov
    Alessandra Ferrajoli
    Guillermo Garcia-Manero
    Maro Ohanian
    William G. Wierda
    Farhad Ravandi
    Jorge E. Cortes
    [J]. Leukemia, 2020, 34 : 2914 - 2924
  • [10] Remission induction in acute myeloid leukemia
    Eytan M. Stein
    Martin S. Tallman
    [J]. International Journal of Hematology, 2012, 96 : 164 - 170
12345